|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Bayer S.A.
Main Activities: Chemical Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Bayer S.A. Previous name(s) Socolan S.A. (1986) Headquarters Av. Paseo de La Republica 3074, Piso 10; Lima; Lima; LIMA 27 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational Fiscal ID (ISIN CODE ): PEP726005007 Fiscal ID (RUC): 20100096341 Financial Auditors: PricewaterhouseCoopers (2010) Incorporation Date: April 2, 1947 Total Employees: 257 Tel: +51-1-2113800 |
|
Company Description |
| Bayer was established on April 2nd, 1947, under the name of SOCOLAN SA, a company in the chemical-pharmaceutical sector. The company produces a wide range of products and services covering the areas of Human and Animal Health (Bayer HealthCare), Crop Nutrition and Care (Bayer CropScience) and Innovative Materials (Bayer MaterialScience). Is listed on the Lima Stock Exchange since 1987. |
Company Analysis |
| According to the Individual - Non-Audited financial statement for the third quarter of 2012, total net operating revenues increased with 5.50%, from PEN 76,020 thousands to PEN 80,202 thousands. Operating result increased from PEN 8,138 thousands to PEN 8,724 thousands which means 7.20% change. The results of the period decreased -22.16% reaching PEN 4,251 thousands at the end of the period against PEN 5,461 thousands last year. Return on equity (Net income/Total equity) went from 2.71% to 1.82%, the Return On Asset (Net income / Total Asset) went from 2.16% to 1.48% and the Net Profit Margin (Net Income/Net Sales) went from 7.18% to 5.30% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 22.38% compared to 25.48% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 4.66 to 5.38 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2012 Q4 (non-cons) |
2012 Q3 (non-cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| BVL-EEFF2 | BVL-EEFF2 | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
297,972 |
286,402 |
| ||
Current Assets |
281,818 |
271,818 |
| ||
Total Liabilities |
50,659 |
52,384 |
| ||
Shareholders Equity |
247,313 |
234,018 |
| ||
Current Liabilities |
47,673 |
50,521 |
| ||
| * All the accounts are in PEN. | ||
Income Statement
| ||
Total Operating Revenue |
88,173 |
80,202 |
| ||
Operational Profit (Loss) |
12,895 |
8,724 |
| ||
Net Profit (Loss) |
13,295 |
4,251 |
| ||
| * All the accounts are in PEN. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
4.46% |
1.48% |
| ||
Return on Equity (ROE) |
5.38% |
1.82% |
| ||
Return on Sales (ROS) |
15.42% |
5.34% |
| ||
Return on Capital |
65.3% |
64.3% |
| ||
Gross Profit Margin |
158.98% |
158.22% |
| ||
Operating Profit Margin |
14.98% |
10.97% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
0.85x |
0.85x |
| ||
Inventory Turnover |
-0.89x |
-0.81x |
| ||
Current asset turnover |
0.31x |
0.29x |
| ||
Fixed-asset turnover |
5.33x |
5.45x |
| ||
Asset Turnover |
0.29x |
0.28x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
112,611 |
105,293 |
| ||
EBITDA |
163,451 |
151,680 |
| ||
Enterprise value |
47,417 |
-50,969 |
| ||
Enterprise Value / EBITDA |
0.29 |
-0.34 |
| ||
Bookvalue (BV) |
243,224 |
229,860 |
| ||
Net Cash |
0 |
0 |
| Liquidity Ratios | ||
| ||
Current Ratio |
591.15% |
538.03% |
| ||
Quick ratio |
471.77% |
425.31% |
| ||
Doom's day ratio |
5.29% |
42.31% |
| Leverage Ratios | ||
| ||
Leverage ratio |
120.48% |
122.38% |
| ||
Interest Coverage Ratio |
-48,501.78% |
-46,814.81% |
| ||
Debt to equity |
20.48% |
22.38% |
| ||
Debt to total assets |
17% |
18.29% |
| ||
Long Term Debt to Capital |
1.19% |
0.79% |
| ||
Debt / Enterprise Value |
106.84% |
-102.78% |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
0.07 |
0.08 |
| ||
Price/Book Ratio |
0.53 |
0.53 |
| Trend Ratios | ||
| ||
Revenue Trend |
93.46% |
93.43% |
| ||
Net Income Trend |
63.81% |
128.46% |
| ||
Operating Income Trend |
108.11% |
93.28% |
| ||
 |